NCT03373461 - Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation | Biotech Hunter

Enrollment

112

Participants

Timeline

Start Date

February 7, 2018

Primary Completion Date

December 29, 2020

Study Completion Date

June 22, 2021

Conditions

IgA Nephropathy

Interventions

DRUG

LNP023

LNP023 5, 25, 100 mg capsles

OTHER

Placebo

Matching placebo to LNP023

Trial Locations (56)

2145

Novartis Investigative Site, Westmead

2650

Novartis Investigative Site, Edegem

3000

Novartis Investigative Site, Leuven

3050

Novartis Investigative Site, Parkville

5021

Novartis Investigative Site, Bergen

8800

Novartis Investigative Site, Roeselare

9000

Novartis Investigative Site, Aalborg

10048

Novartis Investigative Site, Taipei

10330

Novartis Investigative Site, Bangkok

10400

Novartis Investigative Site, Bangkok

12808

Novartis Investigative Site, Prague

13353

Novartis Investigative Site, Berlin

23561

Novartis Investigative Site, New Taipei City

34098

Novartis Investigative Site, Istanbul

34295

Novartis Investigative Site, Montpellier

38039

Novartis Investigative Site, Talas / Kayseri

40705

Novartis Investigative Site, Taichung

41380

Novartis Investigative Site, Kocaeli

49100

Novartis Investigative Site, Petah Tikva

50589

Novartis Investigative Site, Kuala Lumpur

69120

Novartis Investigative Site, Heidelberg

78278

Novartis Investigative Site, Ashkelon

100034

Novartis Investigative Site, Beijing

110029

Novartis Investigative Site, New Delhi

119228

Novartis Investigative Site, Singapore

169608

Novartis Investigative Site, Singapore

200040

Novartis Investigative Site, Shanghai

510080

Novartis Investigative Site, Guangzhou

9112001

Novartis Investigative Site, Jerusalem

C1280AEB

Novartis Investigative Site, Caba

C1015ABO

Novartis Investigative Site, Ciudad Autonoma de Bs As

80440-020

Novartis Investigative Site, Curitiba

90020-090

Novartis Investigative Site, Porto Alegre

Unknown

Novartis Investigative Site, Barranquilla

Novartis Investigative Site, Hong Kong SAR

DK-8200

Novartis Investigative Site, Arhus N

00029

Novartis Investigative Site, HUS

110 017

Novartis Investigative Site, New Delhi

470 1192

Novartis Investigative Site, Toyoake

006-8555

Novartis Investigative Site, Sapporo

981-3205

Novartis Investigative Site, Sendai

700-8558

Novartis Investigative Site, Okayama

530-8480

Novartis Investigative Site, Osaka

9713 GZ

Novartis Investigative Site, Groningen

NO 1478

Novartis Investigative Site, Loerenskog

NO 0450

Novartis Investigative Site, Oslo

03080

Novartis Investigative Site, Seoul

221 85

Novartis Investigative Site, Lund

141 86

Novartis Investigative Site, Stockholm

06100

Novartis Investigative Site, Ankara

CB2 0QQ

Novartis Investigative Site, Cambridge

M6 8HD

Novartis Investigative Site, Salford

LE5 4PW

Novartis Investigative Site, Leicester

SE5 9RS

Novartis Investigative Site, London

NE7 7DN

Novartis Investigative Site, Newcastle upon Tyne